Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy as bladder-sparing therapy in patients with localized muscle invasive bladder cancer: A SOGUG study.

被引：1
|
作者：
Cuellar, M. Andres
Medina, Ana
Girones, Regina
Valderrama, B. P.
Font, Albert
Juanfita, M. J.
de Velasco, Guillermo
Ferrer, Ferran
Vigues, Francesc
Garcia del Muro, Xavier
机构：
[1] Catalan Inst Oncol, Barcelona, Spain
[2] Ctr Oncol Galicia, La Coruna, Spain
[3] Hosp Univ La Fe, Valencia, Spain
[4] Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain
[5] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain
[6] Fdn Inst Valenciano Oncol, Valencia, Spain
[7] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
[8] Inst Catalan Oncol, Barcelona, Spain
[9] Hosp Univ Bellvitge, Barcelona, Spain
[10] Univ Barcelona, Catalan Inst Oncol, IDIBELL, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS5097
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.
    Garcia del Muro, Xavier
    Valderrama, Begona P.
    Medina, Ana
    Andres Cuellar, M.
    Etxaniz, Olatz
    Girones Sarrio, Regina
    Jose Juan-Fita, Maria
    Ferrer, Ferran
    Miras Rodriguez, Isabel
    Lendinez-Cano, Guillermo
    de Haro Piedra, Roberto
    Candal Gomez, Arturo
    Chantada Abal, Venancio
    Salvador Villa, Oscar Buisan
    Luis Pontones, Jose
    Collado, Erica
    Dominguez-Escrig, Jose L.
    Murria, Yashmina
    Vigues, Francesc
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial
    Garcia-del-Muro, Xavier
    P. Valderrama, Begona
    Medina-Colmenero, Ana
    Etxaniz, Olatz
    Sarrio, Regina Girones
    Juan-Fita, Maria Jose
    Costa-Garcia, Marcel
    Moreno, Rafael
    Rodriguez, Isabel Miras
    Ortiz, Irene
    Cuellar, Andres
    Ferrer, Ferran
    Vigues, Francesc
    de Haro Piedra, Roberto
    Candal Gomez, Arturo
    Villa, Salvador
    Pontones, Jose Luis
    Murria, Yasmina
    Lendinez-Cano, Guillermo
    Alemany, Ramon
    CLINICAL CANCER RESEARCH, 2025, 31 (04) : 659 - 666
  • [3] Phase I trial of sorafenib with concurrent radiotherapy (RT) in patients with invasive bladder cancer treated with bladder-sparing intent: A Spanish Oncology Genitourinary Group study.
    Garcia del Muro, X.
    Maroto, J. P.
    Mellado, B.
    Ferrer, F.
    Sancho, G.
    Rovirosa, A.
    Palou, J.
    Ribal, M. J.
    Piulats, J. M.
    Martin Liberal, J.
    Munoz Segui, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Bladder-sparing trimodal therapy for muscle invasive bladder cancer
    Khalifa, J.
    Roumiguie, M.
    Pouessel, D.
    Sargos, P.
    CANCER RADIOTHERAPIE, 2022, 26 (6-7): : 771 - 778
  • [5] Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer
    de Angelis, Mario
    Basile, Giuseppe
    Scornajenghi, Carlo Maria
    Asero, Vincenzo
    Del Giudice, Francesco
    Moschini, Marco
    CURRENT OPINION IN UROLOGY, 2023, 33 (05) : 354 - 359
  • [6] Bladder-sparing treatment options in localized muscle-invasive bladder cancer
    Nason, Gregory J.
    Ajib, Khaled
    Tan, Guan H.
    Kulkarni, Girish S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (03) : 179 - 188
  • [7] Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study
    Verschoor, Noortje
    Heemsbergen, Wilma D.
    Boormans, Joost L.
    Franckena, Martine
    ACTA ONCOLOGICA, 2022, 61 (08) : 1019 - 1025
  • [8] Phase I trial of sorafenib with concurrent radiotherapy (RT) in patients with invasive bladder cancer treated with bladder-sparing intent: A Spanish Oncology Genitourinary Group study
    Martin Liberal, Juan
    Pablo Maroto, Jose
    Mellado, Begona
    Ferrer, Ferran
    Sancho, Gemma
    Rovirosa, Angels
    Vigues, Francesc
    Palou, Joan
    Jose Ribal, Maria
    Bellmunt, Joaquim
    Garcia del Muro, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [9] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [10] Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer
    Ben -David, Reuben
    Galsky, Matthew D.
    Sfakianos, John P.
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (07) : 686 - 697
12345